Cyclic AMP in cerebrospinal fluid of manic and depressive patients
- PMID: 201957
- DOI: 10.1017/s0033291700006231
Cyclic AMP in cerebrospinal fluid of manic and depressive patients
Abstract
Cyclic 3',5'-adenosine monophosphate (c-AMP) was measured in cerebrospinal fluid (CSF) of manic and depressive patients with and without probenecid administration both before and during treatment with various psychotropic drugs. Oral probenecid (100 mg/kg) produced substantial c-AMP accumulations in CSF suggesting a probenecid-sensitive transport mechanism for c-AMP. Baseline and probenecid-induced accumulations of c-AMP were not significantly different in manic and depressed patients, while baseline levels in depressed patients were higher than those in neurological controls. Imipramine, amitriptyline, lithium, tryptophan, and electroconvulsant therapies did not significantly alter levels or accumulations of c-AMP in CSF of depressed patients.
Similar articles
-
Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patients.Neuropsychobiology. 1976;2(4):211-20. doi: 10.1159/000117548. Neuropsychobiology. 1976. PMID: 189250
-
CSF AMP in primary affective disorder: effects of probenecid and tryptophan.Biol Psychiatry. 1980 Feb;15(1):173-6. Biol Psychiatry. 1980. PMID: 6244008 No abstract available.
-
Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.Psychother Psychosom. 1974;23(1-6):142-58. doi: 10.1159/000286638. Psychother Psychosom. 1974. PMID: 4278087 Clinical Trial. No abstract available.
-
Lithium salts in the management of the manic-depressive syndrome.Annu Rev Med. 1972;23:439-52. doi: 10.1146/annurev.me.23.020172.002255. Annu Rev Med. 1972. PMID: 4566490 Review. No abstract available.
-
Neurochemical analysis of cerebrospinal fluid.Neurology. 1980 Jun;30(6):645-51. doi: 10.1212/wnl.30.6.645. Neurology. 1980. PMID: 6155644 Review.
Cited by
-
The effect of ECT on plasma cyclic nucleotides: a simulated ECT controlled study in melancholic patients.Eur Arch Psychiatry Neurol Sci. 1990;239(6):343-6. doi: 10.1007/BF01734539. Eur Arch Psychiatry Neurol Sci. 1990. PMID: 2168317